The study conducted by Schwartz et al. revealed that Ras/MAPK pathway mutations, alterations in RUNX1 or TP53, and KMT2A rearrangements were the most frequently associated with pediatric AML-pCT [6]. This evidence concerns the gene TP53 and acute myeloid leukemia.